BSE filing, NSE: FIVESTAR. Summary written from the filing by ALFA Finder's alert engine.
Five-Star Business Finance Ltd: key numbers
- Share price
- ₹396.85
- Market cap
- ₹11,715 Cr
- Revenue (annual)
- ₹3,218 Cr
- Net profit (annual)
- ₹1,099 Cr
- P/E (TTM)
- 10.5×Sector 19.8×
- Promoter holding
- 18.61%+0.00% QoQ
- FII holding
- 43.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Five-Star Business Finance Ltd
All →Five-Star Business Finance Other Announcement
Five-Star Business Finance filed its quarterly shareholding pattern for the period ended 30 September 2026. This routine Regulation 31 disclosure reports no business event.
Five-Star Business Finance Earnings Call Transcript: Key Takeaways
Five-Star Business Finance reported robust Q2 results with record disbursements and improving asset quality. Management remains highly optimistic about over-delivering on prior growth guidance.
- Call
- Guides 25% growth
Five-Star Business Finance Management Change
Five-Star Business Finance appointed Mr. Shankar Subramanian as Chief Risk Officer for three years from October 26, 2026. Mr. Jayaraman S stepped down from the role due to an internal movement within the Company.
Five-Star Business Finance Q2 FY27 Results: Net Profit ₹299.3 Cr, Up 4.6% YoY
Five-Star Business Finance Ltd reported revenue from operations of ₹858.5 Cr (+7.4% YoY) and net profit of ₹299.3 Cr (+4.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹299.3 Cr · +4.6% YoY
Five-Star Business Finance Results Update
Five-Star Business Finance reported Q2FY27 PAT of Rs.299 Crore, up 5% year-on-year. Disbursements surged 74% to Rs.2,078 Crore, with AUM at Rs.14,640 Crore.
- new branches
- 19.0 branches
Five-Star Business Finance Investor Presentation: Key Takeaways
Q2FY27: PAT ₹2,993 Mn (+5% YoY, +10% QoQ); record disbursals ₹20,778 Mn (+74% YoY); AUM ₹146,396 Mn (+14% YoY); NIM 19.87%; GNPA 3.48%.
Other board meeting date announcements
All →Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.
MKP Mobility Board Meeting Date
MKP Mobility will hold a board meeting on November 6, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results.